Fungal Infections in Immunocompromised Hosts

Front Cover
Dimitrios P. Kontoyiannis, Monica Slavin
MDPI, Apr 2, 2019 - Medical - 212 pages

In this unique supplement, we have compiled several state-of-the-art topics that are based on lectures delivered by eminent mycology experts during the 37th ICHS meeting. We hope that the esteemed audience of the Journal of Fungi will enjoy and appreciate the ever-evolving and complex field of fungal infections in vulnerable hosts. 

 

Selected pages

Common terms and phrases

Agents Chemother allogeneic HSCT amphotericin anidulafungin antifungal therapy antigen Antimicrob aspergillosis Aspergillus fumigatus associated azole blood Bruker system cancer Candida auris candidemia candidiasis caspofungin Child–Pugh Chowdhary chronic Clin CrossRef CrossRef][PubMed Cryptococcus cutaneous cytokines database detection diagnosis of invasive disseminated dosage dose drug echinocandins epidemiology evaluated fluconazole fungi galactomannan hematological malignancies hematopoietic stem cell hepatic impairment host identification immune reconstitution inflammatory immune response immunocompromised immunodeficiency Immunol immunosuppressive invasive aspergillosis invasive candidiasis invasive fungal disease invasive fungal infections invasive pulmonary aspergillosis IRIS isavuconazole isolates itraconazole Kontoyiannis laboratory lesions leukemia liver injury macrophages MALDI-TOF matrix-assisted laser desorption meningitis micafungin Microbiol mold Mycol Mycoses neutropenia neutropenic neutrophil Paracoccidioidomycosis pathogens pediatric patients Pharmacokinetics posaconazole PubMed recommended reconstitution inflammatory syndrome reported risk factors serum species complex Sporothrix schenckii sporotrichosis stem cell transplantation transplant recipients treatment triazoles voriconazole Walsh yeast

About the author (2019)

 Dimitrios P. Kontoyiannis is the Texas 4000 Distinguished Endowed Professor and Deputy Head in the Division of Internal Medicine at MD Anderson Cancer Center in Houston, TX. Dr. Kontoyiannis has authored over 550 peer-reviewed manuscripts and has given over 330 lectures in international conferences and institutions in US and abroad. He is considered a leading mycology expert worldwide with an H index of 98 and over 42,000 citations. His research group is credited for many and sustained contributions to clinical, translational and experimental mycology. He has been the recipient of many national and international awards and was the president elect of Immunocompromised Host Society (2016–2018). 

Monica Slavin is Director of the Department of Infectious Diseases at Peter MacCallum Cancer Centre and a National Health and Medical Research Council funded Centre of Research Excellence in Infections in cancer. She is Professor, in the Department of Medicine, the University of Melbourne. Her research focuses on identifying risk factors, improving early diagnosis, prevention, and treatment of infection, particularly fungal infection in hematology and transplant patients. She was a founding member of the Australasian Society for Infectious Diseases Mycoses Interest Group and is the current president of the International Immunocompromised Host Society.

Bibliographic information

TitleFungal Infections in Immunocompromised Hosts
EditorsDimitrios P. Kontoyiannis, Monica Slavin
Editionillustrated
PublisherMDPI, 2019
ISBN3038977160, 9783038977162
Length212 pages
Subjects › 

Medical / Microbiology
  
Export CitationBiBTeX EndNote RefMan